Rosenwald Lindsay A MD's Form 4 filing
Mustang Bio, Inc. (MBIO) · filed Apr 3, 2023
- Accession no.
- 0001104659-23-040932
- Filed
- Apr 3, 2023
- Trade date
- Mar 18-Sep 13, 2022
- Filing delay
- 381 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.63K. It was filed 381 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rosenwald Lindsay A MDCIK 0000941841 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2022 | COMMON STOCK, PAR VALUE $0.0001 | PPurchaseAcquired | +4,094 | $0.74 | +$3,029.56 | 222,517 | Direct | |
| Jul 29, 2022 | COMMON STOCK, PAR VALUE $0.0001 | AGrant or awardAcquired | +71,664 | $0.00 | $0 | 294,181 | Direct | |
| Sep 13, 2022 | COMMON STOCK, PAR VALUE $0.0001 | PPurchaseAcquired | +5,000 | $0.52 | +$2,600 | 299,181 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.